메뉴 건너뛰기




Volumn 50, Issue 1, 2013, Pages 19-22

Progression of liver fibrosis in monoinfected patients by hepatitis C virus and coinfected by HCV and human immunodeficiency virus

Author keywords

Chronic; Coinfection; Hepacivirus; Hepatitis C; HIV infections; Liver cirrhosis

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MALE; MIXED INFECTION; RETROSPECTIVE STUDY;

EID: 84876880956     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032013000100005     Document Type: Article
Times cited : (11)

References (28)
  • 1
    • 0028898609 scopus 로고
    • Epidemiology of hepatitis C in the West
    • Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis. 1995;15:5-14.
    • (1995) Semin Liver Dis. , vol.15 , pp. 5-14
    • Alter, M.J.1
  • 3
    • 0029778988 scopus 로고    scopus 로고
    • An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group
    • Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289-93.
    • (1996) Hepatology. , vol.24 , pp. 289-293
    • Bedossa, P.1    Poynard, T.2
  • 5
    • 0034917518 scopus 로고    scopus 로고
    • Factors affecting liver fibrosis in human immunodeficiency virus and hepatitis C virus-coinfected patients impact of protease inhibitor therapy
    • MultivirC Group
    • Benhamou Y, Di Martino V, Bochet M, Colombet C, Thibault V, Liou A, Katlama C, Poynard T; MultivirC Group. Factors affecting liver fibrosis in human immunodeficiency virus and hepatitis C virus-coinfected patients impact of protease inhibitor therapy. Hepatology 2001;34:283-7.
    • (2001) Hepatology , vol.34 , pp. 283-287
    • Benhamou, Y.1    Di Martino, V.2    Bochet, M.3    Colombet, C.4    Thibault, V.5    Liou, A.6    Katlama, C.7    Poynard, T.8
  • 7
    • 35248828024 scopus 로고    scopus 로고
    • Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count
    • Bonnard P, Lescure FX, Amiel C, Guiard-Schmid JB, Callard P, Gharakhanian S, Pialoux G. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count. J Viral Hepat. 2007;14:806-11.
    • (2007) J Viral Hepat. , vol.14 , pp. 806-811
    • Bonnard, P.1    Lescure, F.X.2    Amiel, C.3    Guiard-Schmid, J.B.4    Callard, P.5    Gharakhanian, S.6    Pialoux, G.7
  • 10
    • 77952085462 scopus 로고    scopus 로고
    • Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients
    • DallaPiazza M, Amorosa VK, Localio R, Kostman JR, Lo Re V 3 rd. Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients. BMC Infect Dis 2010;10:116-22.
    • (2010) BMC Infect Dis , vol.10 , pp. 116-122
    • DallaPiazza, M.1    Amorosa, V.K.2    Localio, R.3    Kostman, J.R.4    Lo Re III, V.5
  • 11
    • 2542600035 scopus 로고    scopus 로고
    • Risk factors for liver fibrosis progression in patients with chronic hepatitis C
    • De Torres M, Poynard T. Risk factors for liver fibrosis progression in patients with chronic hepatitis C. Ann Hepatol 2003; 2: 5-11.
    • (2003) Ann Hepatol , vol.2 , pp. 5-11
    • de Torres, M.1    Poynard, T.2
  • 12
    • 0035882187 scopus 로고    scopus 로고
    • Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis
    • Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, Koziel MJ. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001;33:562-9.
    • (2001) Clin Infect Dis. , vol.33 , pp. 562-569
    • Graham, C.S.1    Baden, L.R.2    Yu, E.3    Mrus, J.M.4    Carnie, J.5    Heeren, T.6    Koziel, M.J.7
  • 21
    • 67650863603 scopus 로고    scopus 로고
    • Coinfection with hepatitis C virus and human immunodeficiency virus: Virological, immunological, and clinical outcomes
    • Rotman Y, Liang TJ. Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes. J Virol. 2009;83:7366-74.
    • (2009) J Virol. , vol.83 , pp. 7366-7374
    • Rotman, Y.1    Liang, T.J.2
  • 24
    • 44449088871 scopus 로고    scopus 로고
    • There is no difference in hepatic fibrosis rates of patients infected with hepatitis C virus and those co-infected with HIV
    • Souza AR, Tovo CV, Mattos AA, Chaves S. There is no difference in hepatic fibrosis rates of patients infected with hepatitis C virus and those co-infected with HIV. Braz J Med Biol Res. 2008;41:223-8.
    • (2008) Braz J Med Biol Res. , vol.41 , pp. 223-228
    • Souza, A.R.1    Tovo, C.V.2    Mattos, A.A.3    Chaves, S.4
  • 28
    • 0034695289 scopus 로고    scopus 로고
    • Hepatitis C global prevalence (update)
    • World Health Organization
    • World Health Organization. Hepatitis C global prevalence (update). Wkly Epidemiol Rec. 2000;75:17-28.
    • (2000) Wkly Epidemiol Rec. , vol.75 , pp. 17-28


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.